We use cookies to customise content for your subscription and for analytics. If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
Canada - June 28 2011
In Re Immunex Corporation Patent Application No. 583,988, (2011) 89 C.P.R. (4th) 34, the Patent Appeal Board held that broad claims to monoclonal antibodies are allowable in the absence of a working example when the antigen is a novel polypeptide that has been fully characterized, for example, by its complete amino acid sequence.
